Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Aos Bioinnovations LLC holds a patent portfolio in the Biotechnology & Pharmaceuticals technology area. Currently, there is 1 pending office action for the company. This prosecution is being conducted by 1 distinct examiner within 1 distinct art unit.
FONSECA LOPEZ, FRANCINI ALVARENGA is the busiest examiner, with 1 pending office action. This 1 action represents the total of 1 pending office action in the portfolio. This indicates that the company's current biotechnology patent strategy is focused on the feedback from 1 examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FONSECA LOPEZ, FRANCINI ALVARENGA | 1 | 28.6% | +30.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17571774 | Diagnosis of Antibiotic Resistance Genes in Clinical Specimens | FONSECA LOPEZ, FRANCINI ALVARENGA | 34d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17571774 | Diagnosis of Antibiotic Resistance Genes in Clinical Specimens | FONSECA LOPEZ, FRANCINI ALVARENGA | 34d |
| Art Unit | Apps |
|---|---|
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17571774 | Diagnosis of Antibiotic Resistance Genes in Clinical Specimens | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §112 | Final Rejection | 34d | Pending | Jan 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAos Bioinnovations LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Francini Alvarenga Fonseca Lopez has the most, with 1 of Aos Bioinnovations LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
